APA (7th ed.) Citation

Zhou, S., Sheng, L., Zhang, L., Zhang, J., & Wang, L. (2024). METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer. Biochimica et biophysica acta. General subjects, 1868(3), 130542. https://doi.org/10.1016/j.bbagen.2023.130542

Chicago Style (17th ed.) Citation

Zhou, Shaocheng, Lijuan Sheng, Lin Zhang, Jianan Zhang, and Lei Wang. "METTL3/IGF2BP3-regulated M6A Modification of HYOU1 Confers Doxorubicin Resistance in Breast Cancer." Biochimica Et Biophysica Acta. General Subjects 1868, no. 3 (2024): 130542. https://doi.org/10.1016/j.bbagen.2023.130542.

MLA (9th ed.) Citation

Zhou, Shaocheng, et al. "METTL3/IGF2BP3-regulated M6A Modification of HYOU1 Confers Doxorubicin Resistance in Breast Cancer." Biochimica Et Biophysica Acta. General Subjects, vol. 1868, no. 3, 2024, p. 130542, https://doi.org/10.1016/j.bbagen.2023.130542.